Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00285922 · ClinicalTrials.gov registry record
Novel Method to Diagnose Acute Myocardial Ischemia
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 1,320
- Enrollment target
NCT00285922: Completed study, sponsored by University of California, San Francisco.
NCT00285922 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 1,320 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00285922 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 1,320 participants
- Enrollment target
Study Summary
The aim of this study is to improve the detection of heart attack in people who come to a hospital emergency room (ER) with cardiac symptoms. We are testing a novel technology that calculates the heart's electrical activity at points all around the upper body torso and develops a map showing areas indicating heart attack. Our hypothesis is that this new body mapping technique will be better than the standard electrocardiogram (ECG) in detecting heart attack.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,320 participants |
| Start Date | 2001-08 |
| Est. Completion | 2005-12 |
What the finished NCT00285922 record still lists
NCT00285922 is an observational study that tracks outcomes without assigning an intervention. Its 1,320 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00285922 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00285922 about?
NCT00285922 is a clinical study titled "Novel Method to Diagnose Acute Myocardial Ischemia". The aim of this study is to improve the detection of heart attack in people who come to a hospital emergency room (ER) with cardiac symptoms. We are testing a novel technology that calculates the heart's electrical activity at points all around the upper body torso and develops a map showing areas i...
What is the current status of trial NCT00285922?
This trial is currently completed. The enrollment target is 1,320 participants. The study started on 2001-08. Estimated completion is 2005-12.
Who is sponsoring clinical trial NCT00285922?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06557005 · 1,320 participants · NA
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
- NCT07213908 · 1,320 participants · NA
Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
- NCT07144800 · 1,319 participants · NA
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
- NCT05097287 · 1,324 participants · Phase 4
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia